Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 1998;83:966-968

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hasenfuss, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hasenfuss, G.
(Circulation Research. 1998;83:966-968.)
© 1998 American Heart Association, Inc.


Editorial

Calcium Pump Overexpression and Myocardial Function

Implications for Gene Therapy of Myocardial Failure

Gerd Hasenfuss

Correspondence to Gerd Hasenfuss, MD, Universität Göttingen, Zentrum Innere Medizin, Abteilung Kardiologie und Pneumologie, Robert-Koch-Strasse 40, 37075 Göttingen, Germany. E-mail hasenfus@med.uni-goettingen.de


Key Words: Ca2+-ATPase overexpression • myocardium • gene therapy • heart failure

The contraction-relaxation cycle of the heart is controlled by the sequential rise and fall of the cytosolic calcium concentration. Calcium entry through L-type calcium channels during the action potential serves to trigger calcium release from the sarcoplasmic reticulum (SR) leading to activation of contractile proteins and force generation (for review, see Reference 11 ). In addition, there is calcium influx by reverse-mode sodium-calcium exchange. The contribution of calcium influx through L-type calcium channels, or sodium calcium exchange, and of SR calcium release to systolic calcium transients differs from species to species.2 The global increase in calcium is immediately followed by calcium removal, resulting in subsequent deactivation of the contractile machinery and myocardial relaxation. Calcium removal from the cytosol occurs by the activity of the SR pump, by exchange of calcium for sodium via the sarcolemmal sodium-calcium exchanger (Na+-Ca2+ exchanger), by mitochondrial calcium uptake, and by calcium extrusion via the sarcolemmal calcium pump.1 Again, the contribution of these systems removing calcium from the cytosol to the decay of the calcium transient and to subsequent relaxation varies in a species-dependent manner. Using the rapid-cooling contracture technique, Bers et al suggested that in rat ventricular myocardium, {approx}92% of calcium removal occurs by SR calcium uptake and only {approx}7% by Na+-Ca2+ exchange.3 4 In other species (human, rabbit, ferret, cat, and guinea pig) the balance is more in the range of 70% to 75% SR calcium uptake and 25% to 30% Na+-Ca2+ exchange.3 4 According to these studies, calcium uptake by mitochondria and . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
L. S. Maier, C. Wahl-Schott, W. Horn, S. Weichert, C. Pagel, S. Wagner, N. Dybkova, O. J. Muller, M. Nabauer, W.-M. Franz, et al.
Increased SR Ca2+ cycling contributes to improved contractile performance in SERCA2a-overexpressing transgenic rats
Cardiovasc Res, September 1, 2005; 67(4): 636 - 646.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. Lohn, M. Furstenau, V. Sagach, M. Elger, W. Schulze, F. C. Luft, H. Haller, and M. Gollasch
Ignition of Calcium Sparks in Arterial and Cardiac Muscle Through Caveolae
Circ. Res., November 24, 2000; 87(11): 1034 - 1039.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. E. Lehnart, P. M. L. Janssen, W. M. Franz, J. K. Donahue, J. H. Lawrence, E. Marban, J. Prestle, and G. Hasenfuss
Preservation of myocardial function after adenoviral gene transfer in isolated myocardium
Am J Physiol Heart Circ Physiol, September 1, 2000; 279(3): H986 - H991.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
R. J. Hajjar, F. del Monte, T. Matsui, and A. Rosenzweig
Prospects for Gene Therapy for Heart Failure
Circ. Res., March 31, 2000; 86(6): 616 - 621.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. I. Miyamoto, F. del Monte, U. Schmidt, T. S. DiSalvo, Z. B. Kang, T. Matsui, J. L. Guerrero, J. K. Gwathmey, A. Rosenzweig, and R. J. Hajjar
Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure
PNAS, January 18, 2000; 97(2): 793 - 798.
[Abstract] [Full Text] [PDF]